CANNAPHARMARX, INC.
BioSniper Score
Based on 3 of 6 signals
Limited data coverage
Market Cap
$1.6M
Cash Runway
3.4 mo
Lead Asset
Dried cannabis flower
Next Catalyst
—
Tracking 1 pipeline candidate for CANNAPHARMARX, INC. · Updated within the last hour.
Go deeper on CANNAPHARMARX, INC. with Spotter
Ask follow-up questions and run a full multi-agent deep dive on CPMD — live, with citations.
Score breakdownBased on 3 of 6 signals · derived from public data
3.4 months
OCF -$244K · Net income -$382K
No tracked pipeline phase
1 candidate
No upcoming catalysts tracked
No insider transactions in the last 180 days
Key Financialsas of March 31, 2026
Cash
$633
Quarterly Burn
$244K
Revenue
$627K
Free Cash Flow
-$244K
Total Liabilities
$36.9M
Shareholders Equity
-$30.3M
Current Ratio
0.03
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (1 candidate)
| Drug | Phase |
|---|---|
| Dried cannabis flower | — |
Commercialization & Governance
Commercialization
- Partnerships
- LTB Management, LLC (for sales network development and e-commerce technology in the EU)
- Launch Markets
- GermanyIsrael
- Commercial Strategy
- The company intends to grow by increasing production capacity to support sales in European markets, specifically Germany and Israel, and is building a sales network in these regions.
Frequently asked questions
Who is the CEO of CANNAPHARMARX, INC.?
Mr. Constantine Nkafu is the chief executive officer of CANNAPHARMARX, INC. (CPMD).
Where is CANNAPHARMARX, INC. headquartered?
CANNAPHARMARX, INC. (CPMD) is headquartered in Cremona, AB, Canada.
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.
Get the full picture on CANNAPHARMARX, INC.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.